Technology Industry
Industry: Email Alert RSS Feed- BT Catalyst
- Reports on new biotechnology activities and developments with special emphasis on university and industry programs, and results in the state of North Carolina.
Most Recent Articles from BT Catalyst 
Biolex Therapeutics of Pittsboro closed on a $30 million Series C financing led by Investor Growth Capital of New York and including two other new investors,...
Biolex Therapeutics of Pittsboro closed on a $30 million Series C financing led by Investor Growth Capital of New York and including two other new...
7/1/07 · More from publicationViamet Pharmaceutical, a Research Triangle park biotechnology company targeting metalloenzymes in the fields of infectious disease, inflammation and oncology,...
Viamet Pharmaceutical, a Research Triangle park biotechnology company targeting metalloenzymes in the fields of infectious disease, inflammation and...
7/1/07 · More from publicationAAIPharma of Wilmington has acquired Instituto de Pesquisa Clinica de Sao Paulo
AAIPharma of Wilmington has acquired Instituto de Pesquisa Clinica de Sao Paulo, a contract research organization providing clinical development...
7/1/07 · More from publicationSerenex, of Durham, has secured $31 million in financing, including a $26 million Series D private placement of preferred stock and a $5 million working...
Serenex, of Durham, has secured $31 million in financing, including a $26 million Series D private placement of preferred stock and a $5 million...
7/1/07 · More from publicationThe Piedmont Angel Network Two , a structured, committed capital angel fund located in Greensboro, led the initial closing of the first half of a $1.5 million...
The Piedmont Angel Network Two (PAN Two), a structured, committed capital angel fund located in Greensboro, led the initial closing of the first half...
7/1/07 · More from publicationOncoMethylome Sciences, a molecular diagnostics company based in Belgium with operations in Durham, has been awarded a research grant of 1.95 million [euro] by...
OncoMethylome Sciences, a molecular diagnostics company based in Belgium with operations in Durham, has been awarded a research grant of 1.95 million...
7/1/07 · More from publication
